Amentoflavone alleviated cartilage injury and inflammatory response of knee osteoarthritis through PTGS2
Naunyn-Schmiedeberg's Archives of Pharmacology · 2024
DOI: 10.1007/s00210-024-03222-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Yiheng Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Yantaishan Hospital, Yantai, 264000, Shandong, China. Hauptthemen laut MEDLINE: Cyclooxygenase 2, Biflavonoids, Osteoarthritis, Knee, Chondrocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Focus on research and development plan in Shandong province, Shandong medicine and Health Science and Technology Development Plan Projec, Major research program of science and technology bureau in Yantai city.
Abstract (Originalsprache)
The role of amentoflavone on cartilage injury in knee osteoarthritis (KOA) rats and the underlying mechanism were explored. KOA rat and IL-1β-stimulated chondrocyte models were constructed. MTT, colony formation, and ELISA were performed to determine the cytotoxicity, cell proliferation, and inflammatory factors. The role of PTGS2 in IL-1β-stimulated chondrocytes was also confirmed through transfecting PTGS2 overexpression and silencing plasmids. Further, we analyzed how amentoflavone regulated PTGS2 to improve IL-1β-stimulated chondrocytes in vitro. Additionally, we analyzed the expression of PTGS2 after amentoflavone treatment. In vivo, HE and Safranin-O staining were carried out, and the inflammatory response was detected by ELISA and HE staining. In addition, we also analyzed the regulatory effect of amentoflavone on PTGS2 and explored the mechanism effect of PTGS2 in vitro and in vivo. The results indicated that PTGS2 was the downstream molecule of amentoflavone, which was highly expressed in IL-1β-stimulated chondrocytes and KOA rats, and amentoflavone decreased PTGS2 expression. We also confirmed the potential role of amentoflavone on KOA, which was also characterized by the repair of cartilage injury, reduction of inflammatory infiltration, and improvement of functional disability. Consistent with in vivo results, in vitro experiments gave the same conclusions. Amentoflavone reduced PTGS2 expression in IL-1β-stimulated chondrocytes and inhibited inflammation of chondrocytes via PTGS2. Collectively, the results confirmed that this drug was the potential targeted drug for KOA, whose repair effect on cartilage injury was partly related to PTGS2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Yantaishan Hospital, Yantai, 264000, Shandong, China.
- Department of Traumatic Orthopaedics, Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, Shandong, China.
- Department of Hand and Foot Surgery, Yantai Yuhuangding Hospital of Qingdao University, 20 Yuhuangding East Road, Yantai, 264000, Shandong, China. xwqytyhdyy@163.com.
Förderung
- Focus on research and development plan in Shandong province
- Shandong medicine and Health Science and Technology Development Plan Projec
- Major research program of science and technology bureau in Yantai city
Zitieren
APA
Cheng, Y., Liu, X., Qu, W., Wang, X., Su, H., Li, W., & Xu, W. (2024). Amentoflavone alleviated cartilage injury and inflammatory response of knee osteoarthritis through PTGS2. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03222-4
Vancouver
Cheng Y, Liu X, Qu W, Wang X, Su H, Li W, et al. Amentoflavone alleviated cartilage injury and inflammatory response of knee osteoarthritis through PTGS2. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03222-4
BibTeX
@article{Cheng2024,
author = {Cheng, Yiheng and Liu, Xiaofeng and Qu, Wenqing and Wang, Xin and Su, Hao and Li, Wenliang and Xu, Wenqiang},
title = {Amentoflavone alleviated cartilage injury and inflammatory response of knee osteoarthritis through PTGS2},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2024},
doi = {10.1007/s00210-024-03222-4}
}
EUVIMED